Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy

Globally, human immunodeficiency virus type 1 (HIV-1) infection is a major health burden for which successful therapeutic options are still being investigated. Challenges facing current drugs that are part of the established life-long antiretroviral therapy (ART) include toxicity, development of dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Hager, Gurrola, Theodore, Berman, Rachel, Collins, Mackenzie, Sariyer, Ilker K., Nonnemacher, Michael R., Wigdahl, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811197/
https://www.ncbi.nlm.nih.gov/pubmed/35126374
http://dx.doi.org/10.3389/fimmu.2021.816515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811197/
https://www.ncbi.nlm.nih.gov/pubmed/35126374
http://dx.doi.org/10.3389/fimmu.2021.816515

Ejemplares similares